Elphis Cell Therapeutics
PrivateLast Round
Series A
Extension
Jan 21, 2024
Total Funding Raised
$6.72M
Company Overview
Elphis Cell Therapeutics operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A Extension round in January 2024.
Elphis Cell Therapeutics is a biotechnology company that develops personalized cell therapies for intractable vascular diseases using complex stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elphis Cell Therapeutics Comparables
Compare Elphis Cell Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BREXOGEN Inc. | 69% | |
| SCM Lifescience | 69% | |
| Bio Solution Co.,Ltd. | 66% |
For institutional investors. Book with your work email.
Elphis Cell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 21, 2024 | ||||
| Series A | Oct 12, 2023 |
For institutional investors. Book with your work email.
Elphis Cell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BSK Investment | Series A |
| Pathfinder H | Series A Extension, Series A |
| The Turning Point | Series A |
| Daekyo Investment | Series A, Series A Extension |
| LK Technology Investment | Series A |
Elphis Cell Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elphis Cell Therapeutics's valuation, stock price, and market status.
Is Elphis Cell Therapeutics a public or private company?
Elphis Cell Therapeutics is a private company.
What is the current stock price of Elphis Cell Therapeutics?
Elphis Cell Therapeutics is a private company, so its shares have no public market price. Caplight tracks Elphis Cell Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elphis Cell Therapeutics worth (valuation)?
Valuation information for Elphis Cell Therapeutics is not publicly available.
Can I buy Elphis Cell Therapeutics stock?
Elphis Cell Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elphis Cell Therapeutics's last funding round?
Elphis Cell Therapeutics's most recent funding round was Series A Extension on January 21, 2024.
Who are the main investors in Elphis Cell Therapeutics?
Key investors in Elphis Cell Therapeutics include Daekyo Investment.
Will Elphis Cell Therapeutics IPO soon?
No public IPO plans have been announced for Elphis Cell Therapeutics.
How can I track Elphis Cell Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Elphis Cell Therapeutics's shares on secondary markets.